Precise Oncology and mRNA Vaccines: Advances in Pancreatic Cancer Treatment
In April 2026, precision oncology marked a significant advancement for pancreatic ductal adenocarcinoma (PDAC), with the first personalized mRNA vaccine demonstrating sustained immune responses and delayed recurrence in a subset ... Read More